MAPT and cardiac arrest: A multicenter study16 that examined biobank samples from 717 adults with cardiac arrest who participated in a randomized clinical trial also found that NfL concentration was the best-performing biomarker compared with neuron-specific enolase, S100 calcium-binding protein B, and tau for the assessment of unfavorable outcomes based on the Cerebral Performance Category Scale at 6 months.